1 |
Kim HY, Kang YJ, Song IH, Choi HC, Kim HS. Upregulation of interleukin-8/CXCL8 in vascular smooth muscle cells from spontaneously hypertensive rats. Hypertens Res 31: 515−523, 2008
DOI
ScienceOn
|
2 |
Kim JA, Gu JL, Natarajan R, Rerliner JA, Nadler JL. A leukocyte type 12-lipoxygenase is expressed in human vascular and mononuclear cells. Evidence for upregulation by angiotensin II. Arterioscler Thromb Vasc Bio 15: 942−948, 1995
DOI
PUBMED
ScienceOn
|
3 |
Lee HM, Lee CK, Lee SH, Roh HY, Bae YM, Lee KY. p38 mitogen- activated protein kinase contributes to angiotensin II-stimulated migration of rat aortic smooth muscle cells. J Pharmacol Sci 105: 74−81, 2007
DOI
PUBMED
ScienceOn
|
4 |
Natarajan R, Rosdahl J, Gonzales N, Bai W. Regulation of 12-lipoxygenase by cytokine in vascular smooth muscle cells. Hypertension 30: 873−879, 1997
PUBMED
ScienceOn
|
5 |
Resink TJ, Scott-Burden T, Burgin M, Buhler FR. Enhanced responsiveness to angiotensin II in vascular smooth muscle cells from spontaneously hypertensive rats is not associated with alterations in protein kinase C. Hypertension 14: 293−303, 1989
DOI
PUBMED
|
6 |
Rouiz-Ortega M, Lorenzo O, Ruperez M, Konig S, Wittig B, Egido J. Angiotensin II activates nuclear transcription factor Kappa B through At1 and At2 in vascular smooth muscle cells: molecular mechanisms. Circ Res 86: 1266−1272, 2000
DOI
PUBMED
ScienceOn
|
7 |
Touyz RM, Mabrouk ME, He G, Wu X-H, Schiffrin EL. Mitogen- activated protein/extracellular signal-regulated kinase inhibition attenuates angiotensin II-mediated signaling and contraction in spontaneously hypertensive rat vascular smooth muscle cells. Circ Res 84: 505−515, 1999
DOI
PUBMED
ScienceOn
|
8 |
Viedt C, Soto U, Krieger-brauer HI, Fei J, Elsing C, Kubler W. Differential activation of mitogen-activated protein kinase in smooth muscle cells by angiotensin II: involvement of p22phox and reactive oxygen species. Arterioscler Thromb Vasc Biol 20: 940−948, 2000
DOI
PUBMED
ScienceOn
|
9 |
Wolf G, Wenzel U, Burns KD, Harris RC, Stahl RA, Thaiss F. Angiotensin II activates nuclear transcription factor-B through and receptors. Kidney Int 61: 1986−1995, 2002
DOI
PUBMED
ScienceOn
|
10 |
Zoja C, Donadelli R, Colleoni S, Figliuzzi M, Bonazzola S, Morigi M. Protein overload stimulates RANTES production by proximal tubular cells depending on NF-B activation. Kidney Int 53: 1608−1615, 1998
DOI
PUBMED
ScienceOn
|
11 |
Jordan NJ, Watson ml, Williams RJ, Roach AG, Yoshimura T, Westwick J. Chemokine production by human vascular smooth muscle cells: modulation by IL-13. Br J Pharmacol 122: 749−757, 1997
DOI
PUBMED
ScienceOn
|
12 |
Bedecs K, Elbaz N, Sutren M, Masson M, Susini C, Strosberg AD. Angiotensin II type 2 receptors mediate inhibition of mitogen activated protein kinase cascade and functional activation of SHP-1 tyrosine phosphatase. Biochem J 325: 449−454, 1997
DOI
ScienceOn
|
13 |
Buemi M, Marino D, Floccari F, Ruello A, Nostro L, Aloisi C. Effect of interleukin 8 and ICAM-1 on calcium-dependent outflow of in erythrocytes from subjects with essential hypertension. Curr Med Res Opin 20: 19−24, 2004
DOI
PUBMED
ScienceOn
|
14 |
Gonzalez-Nunez D, Claria J, Rivera F, Roch E. Increased levels of 12(S)-HETE in patients with essential hypertension. Hypertension 37: 334−338, 2001
DOI
PUBMED
ScienceOn
|
15 |
Wolf G, Ziyadeh FN, Thaiss F, Tomaszewski J, Caron RJ, Wenzel U. Angiotensin II stimulates expression of the chemokine RANTES in rat glomerular endothelial cells. J Clin Invest 100: 1047−1058, 1997
DOI
PUBMED
ScienceOn
|
16 |
Han Y, Runge MS, Brasier AR. Angiotensin II induced interleukin-6 transcription in vascular smooth muscle cells through pleiotropic activation of nuclear factor-B transcription factor. Circ Res 84: 695−703, 1999
DOI
PUBMED
ScienceOn
|
17 |
Kashiwagi M, Masutani K, Shinozaki M, Hirakata H. MCP-1 and RANTES are expressed in renal cortex of rats chronically treated with nitric oxide synthase inhibitor. Nephron 92: 165−173, 2002
DOI
PUBMED
ScienceOn
|
18 |
Preston IR, Hill NS, Warburton RR, Fanburg BL. Role of 12-lipoxygenase in hypoxia-induced rat pulmonary artery smooth muscle cell proliferation. Am J Lung Cell Mol Physiol 290: L367−L374, 2006
DOI
|
19 |
Zhao M, Liu Y, Bao M, Kato Y, Han J, Eaton JW. Vascular smooth muscle cell proliferation requires both p38 and BMK1 MAP kinases. Arch Biochem Biophys 400: 199−207, 2002
DOI
PUBMED
ScienceOn
|
20 |
Gallinat S, Busche S, Raizada MK, Sumners C. The angiotesin II type 2 receptor: An enigma with multiple variations. Am J Physiol 278: E357−E374, 2000
|
21 |
Horiuchi M, Lehtonen JY, Daviet L. Signaling mechanism of the angiotensin II receptor: crosstalk between and receptors in cell growth. Trends Endocrinol Metab 10: 391−396, 1999
DOI
ScienceOn
|
22 |
Ishibashi M, Hiasa KI, Zhao Q, Inoue S, Ohtani K, Kitamoto S. Critical role of monocyte chemoattractant protein-1 receptor CCR2 on monocyte in hypertension-induced vascular inflammation and remodeling. Circ Res 94: 1203−1210, 2004
DOI
PUBMED
ScienceOn
|
23 |
Shahrara S, Park CC, Temkin V, Jarvis JW, Volin MV, Pope RM. RANTES modulates TLR4-induced cytokine secretion in human peripheral blood monocytes. J Immunol 177: 5077−5087, 2006
DOI
|
24 |
Mabrouk ME, Touyz RM, Schiffrin EL. Differential Ang II-induced growth activation pathways in mesenteric artery smooth muscle cells from SHR. Am J Physiol Heart Circ Physiol 281: H30−H39, 2001
DOI
PUBMED
|
25 |
Tripathy D, Thirumangalakudi L, Grammas P. RANTES upregulation in the Alzheimer's disease brain: a possible neuroprotective role. Neurobiol Aging doi:10.1016/j.neurobiol aging 2008.03.009
DOI
|
26 |
Sasaki M, Hori MT, Hino T, Golub MS, Tuck ml. Elevated 12-lipoxygenase activity in the spontaneously hypertensive rat. Am J Hypertens 10: 371−378, 1997
PUBMED
ScienceOn
|
27 |
Horiuchi M, Akishita M, Dzau VJ. Recent progress in angiotensin II type 2 receptor research in the cardiovascular system. Hypertension 33: 613−621, 1999
DOI
PUBMED
ScienceOn
|
28 |
Natarajan R, Gi JL, Rossi J, Gonzales N, Lanting L, Xu L. Elevated glucose and angiotensin II increase 12-lipoxygenase activity and expression in porcine aortic smooth muscle cells. Proc Natl Acad Sci USA 90: 4947−4951, 1993
DOI
ScienceOn
|
29 |
Wolf G, Neilson EG. From converting enzyme inhibition to angiotensin II receptor blockade: New insight on angiotensin II receptor subtypes in the kidney. Exp Nephrol 4: 8−19, 1996
PUBMED
ScienceOn
|
30 |
Dorfm?ller P, Zarka V, Durand-Gasselin I, Monti G, Balabanian K, Garcia G. Chemokine RANES in severe pulmonary arterial hypertension. Am J Respir Crit Care Med 165: 534−539, 2002
DOI
PUBMED
ScienceOn
|
31 |
Saward L, Zahradka P. The angiotensin type 2 receptor mediates RNA synthesis in A10 vascular smooth muscle cells. J Mol Cell Cardiol 28: 499−506, 1996
DOI
PUBMED
ScienceOn
|
32 |
Wilkie N, Ng LL, Boarder MR. Angiotensin II responses of vascular smooth muscle cells from hypertensive rats: enhancedment at the level of p42 and p44 mitogen activated protein kinase. Br J Pharmacol 122: 209−216, 1997
DOI
PUBMED
ScienceOn
|
33 |
Schall TJ, Bacon K, Toy KJ, Goeddel DV. Selective attraction of monocytes and T lymphocytes of the memory phenotype by cytokine RANTES. Nature 347: 669−671, 1990
DOI
PUBMED
ScienceOn
|
34 |
Chen XL, Tummala PE, Olbrych MT, Alexander RW, Medford RM. Angiotensin II induces monocyte chemoattractant protein-1 gene expression in rat vascular smooth muscle cells. Circ Res 83: 952−959, 1998
DOI
PUBMED
ScienceOn
|
35 |
Wei LH, Yang Y, Wu G, Ignarro LJ. IL-4 and IL-13 upregulate ornithine decarboxylase expression by PI3K and MAP kinase pathways in vascular smooth muscle cells. Am J Physiol Cell Physiol 294: C1198−C1205, 2008
DOI
PUBMED
ScienceOn
|
36 |
Zheng Y, Song HJ, Yun SH, Chae YJ, Jia H, Kim CH, Ha TS, Sachinidis A, Ahn HY, Davidge ST. Inhibition of angiotensin ii-induced vascular smooth muscle cell hypertrophy by different catechins. Korean J Physiol Pharmacol 9: 117−123, 2005
과학기술학회마을
ScienceOn
|